'Project Runway' Designer in D.C. to Educate About Living with HIV and Combat Stigma Associated with the Disease Through Living Positive By Design

WASHINGTON, April 19 /PRNewswire/ -- Jack Mackenroth, from the hit reality television series "Project Runway," is visiting Washington, D.C. for Whitman-Walker Clinic's 17th Annual Spring Gala, Masquerade on the Mall, and is bringing Living Positive By Design, his national HIV and AIDS education initiative supported by Merck, to the city.  On Friday, April 23, Jack will host the Gala, which helps to support Whitman-Walker Clinic and the thousands of patients in the D.C. area that benefit from its care.

"I'm proud to be able to bring Living Positive By Design to our nation's capital, especially given that this city has the highest HIV and AIDS prevalence rate in the U.S.," said Mackenroth, who has been living with HIV for more than 20 years.  "While in D.C., I want to highlight the importance of people living with HIV to work with their physicians to find a tolerable treatment regimen that can reduce the amount of virus in their blood.  Given all the treatment options that are available today, people living with HIV need to know the importance of proper disease management to help them maintain a good quality of life."

The Living Positive By Design campaign seeks to help combat the stigma associated with HIV by engaging people in thoughtful conversation about the disease.  Since the launch of Living Positive By Design in 2008, Jack has visited nine cities, brining the campaign's messages to cities hardest hit by the HIV epidemic.  He will continue to raise awareness about HIV and AIDS through events in additional cities throughout 2010.  For more information on Living Positive By Design, please visit: www.LivingPositiveByDesign.com.

"Whitman-Walker Clinic is proud to have Jack Mackenroth join us as the host of our 17th Annual Spring Gala," said Don Blanchon, Executive Director of Whitman-Walker Clinic.  "As a community leader in the fight against HIV/AIDS and as one of the oldest and largest HIV health centers in the Washington, D.C. area, Whitman-Walker Clinic, like the Living Positive By Design campaign, works to highlight the importance for people living with HIV to have a positive outlook on life while effectively managing their disease and works to combat the stigma still associated with HIV."

Prevalence of HIV and AIDS

According to the Centers for Disease Control and Prevention (CDC), more than one million Americans are living with HIV and AIDS in the U.S. and approximately 55,000 new people become infected every year. A 2008 report from the Washington, D.C. Department of Health showed that the city had an HIV prevalence rate of three percent, the highest in the nation. Additionally, nearly 70 percent of the HIV and AIDS cases in D.C. were in men and 76 percent were in African-Americans.

About Merck

Today's Merck is working to help the world be well.  Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions.  We also demonstrate our commitment to increasing access to health care through far-reaching programs that donate and deliver our products to the people who need them.  Merck.  Be Well.  For more information, visit www.merck.com.

Forward-looking statement

This news release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.  Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future financial and operating results, the combined company's plans, objectives, expectations and intentions and other statements that are not historical facts.  Such statements are based upon the current beliefs and expectations of Merck's management and are subject to significant risks and uncertainties.  Actual results may differ from those set forth in the forward-looking statements.

The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: the possibility that the expected synergies from the merger of Merck and Schering-Plough will not be realized, or will not be realized within the expected time period, due to, among other things, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry; the risk that the businesses will not be integrated successfully; disruption from the merger making it more difficult to maintain business and operational relationships; Merck's ability to accurately predict future market conditions; dependence on the effectiveness of Merck's patents and other protections for innovative products; the risk of new and changing regulation and health policies in the U.S. and internationally and the exposure to litigation and/or regulatory actions.

Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.  Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck's 2009 Annual Report on Form 10-K and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site (www.sec.gov).

SOURCE Living Positive By Design

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED